SEC Form 4 · accession 0001127602-17-031738

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Chief Accounting Officer

Period of report

Nov 7, 2017

Accepted (ET)

Nov 9, 2017 · 4:18 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 7, 2017	M	217	$146.93	A	1,222	D
Common Stock	Nov 7, 2017	M	405	$131.80	A	1,627	D
Common Stock	Nov 7, 2017	M	356	$166.97	A	1,983	D
Common Stock	Nov 7, 2017	S	978	$217.42	D	1,005	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F1	$146.93	Nov 7, 2017	M	217	D	—	Mar 2, 2025	Common Stock	217	217	D
Employee Stock Option (Right to Buy)^F2	$131.80	Nov 7, 2017	M	405	D	—	Mar 1, 2026	Common Stock	405	1,217	D
Employee Stock Option (Right to Buy)^F3	$166.97	Nov 7, 2017	M	356	D	—	Mar 1, 2027	Common Stock	356	1,785	D

F1The option represents a right to purchase a total of 1,301 shares, became exercisable in six semi-annual installments, with one installment of 216 shares and five installments of 217 shares each, beginning on September 2, 2015, which was the six-month anniversary of the option grant date.
F2The option represents a right to purchase a total of 2,432 shares, and is exercisable in six semi-annual installments, with four installments of 405 shares each and two installments of 406 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
F3The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.